Study of TAK-901 in Adults With Advanced Solid Tumors or Lymphoma
NCT00935844
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Lymphoma
Interventions
DRUG:
TAK-901
Sponsor
Millennium Pharmaceuticals, Inc.